Back to News
Market Impact: 0.12
Wave Life Sciences Names Monika Vnuk Chief Business Officer
Source: Nasdaq
Healthcare & BiotechManagement & Governance
Wave Life Sciences appointed Monika Vnuk as chief business officer, adding her to the executive team to lead business development and corporate development. The leadership appointment is strategically relevant for the clinical-stage RNA medicines company but contains no disclosed financial or clinical catalyst.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
WVE0.25
More News
- Paraguay’s Santiago Pena under arrest, new president Pedro Alliana sworn in
- Fox wraps up its $22 billion Roku deal
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- How Paraguay’s Ueno collapse is only its latest banking crisis
- Do not investigate Trump’s corporate allies until he leaves office
- Apollo-backed dental firm vVardis seeks up to $229 million in US IPO